Drugs / CS060304
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06485245 | Apr → Nov 2025 overdue | — | Cascade Pharmaceuticals, Inc | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS060304 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06485245 ↗ |
| Route | Oral | “Tablets administered orally” NCT06485245 ↗ |